Literature DB >> 8317825

Structure and function of the estrogen receptor.

M G Parker1, N Arbuckle, S Dauvois, P Danielian, R White.   

Abstract

The hormone binding domain of the estrogen receptor is required not only for binding estradiol but also to form stable homodimers of the protein and mediate transcriptional activation by the receptor. Residues that are essential for estrogen binding are also involved in dimerization, suggesting that the hormone-binding pocket is at or near the dimer interface. Distinct hydrophobic and charged residues are essential for hormone-dependent transcriptional activation, and these appear to be conserved by other members of the nuclear receptor family. We have found that the pure antiestrogens ICI 164384 and ICI 182780 increase the turnover of the receptor compared with that in the presence of estradiol. Because it is likely that the pure antiestrogens bind to a similar region of the receptor as that of estradiol, we propose that they inhibit receptor dimerization by means of their 7 alpha alkyl-amide extension. It appears that as a consequence nuclear uptake is inhibited and the receptor more rapidly degraded in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317825     DOI: 10.1111/j.1749-6632.1993.tb32276.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  Steroid receptor specificity with reference to the estrogen receptor.

Authors:  G H Williams
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.

Authors:  Crystal E Berger; Yingjuan Qian; Gang Liu; Hongwu Chen; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

Review 3.  Re-adopting classical nuclear receptors by cholesterol metabolites.

Authors:  Michihisa Umetani
Journal:  J Steroid Biochem Mol Biol       Date:  2015-11-10       Impact factor: 4.292

4.  Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.

Authors:  Huanlei Wu; Li Xu; Jigui Chen; Junbo Hu; Shiying Yu; Guangyuan Hu; Liu Huang; Xiaoping Chen; Xianglin Yuan; Guojun Li
Journal:  BMC Cancer       Date:  2012-07-03       Impact factor: 4.430

5.  G-protein-coupled receptor participates in 20-hydroxyecdysone signaling on the plasma membrane.

Authors:  Mei-Juan Cai; Du-Juan Dong; Yu Wang; Peng-Cheng Liu; Wen Liu; Jin-Xing Wang; Xiao-Fan Zhao
Journal:  Cell Commun Signal       Date:  2014-02-10       Impact factor: 5.712

6.  Estrogen receptor α gene polymorphism and vascular complications in girls with type 1 diabetes mellitus.

Authors:  Bartosz Słomiński; Jolanta Myśliwska; Monika Ryba-Stanisławowska; Maria Skrzypkowska; Małgorzata Myśliwiec
Journal:  Mol Cell Biochem       Date:  2017-06-20       Impact factor: 3.396

7.  Association between the estrogen receptor α gene polymorphisms rs2234693 and rs9340799 and severe and mild pre-eclampsia: a meta-analysis.

Authors:  Ge Zhao; Yunfei Cai; Jing Liu; Tao Meng
Journal:  Biosci Rep       Date:  2019-02-08       Impact factor: 3.840

8.  G protein coupled estrogen receptor attenuates mechanical stress-mediated apoptosis of chondrocyte in osteoarthritis via suppression of Piezo1.

Authors:  Yi Sun; Ping Leng; Pengcheng Guo; Huanshen Gao; Yikai Liu; Chenkai Li; Zhenghui Li; Haining Zhang
Journal:  Mol Med       Date:  2021-08-28       Impact factor: 6.354

Review 9.  Nuclear receptors modulate inflammasomes in the pathophysiology and treatment of major depressive disorder.

Authors:  Han Wang; Wei-Jing Kan; Yuan Feng; Lei Feng; Yang Yang; Pei Chen; Jing-Jie Xu; Tian-Mei Si; Ling Zhang; Gang Wang; Jing Du
Journal:  World J Psychiatry       Date:  2021-12-19

10.  Rapid screening of environmental chemicals for estrogen receptor binding capacity.

Authors:  R Bolger; T E Wiese; K Ervin; S Nestich; W Checovich
Journal:  Environ Health Perspect       Date:  1998-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.